Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.51T
| $103M | 1.65% |
2,084,364
-166,884
| -7% | -$8.13M |
|
2
Honeywell
HON
$68.4B
| $69.1M | 1.1% |
419,746
-93,975
| -18% | -$15M |
|
3
IBM
IBM
$222B
| $65M | 1.04% |
492,998
-12,840
| -3% | -$1.69M |
|
|
4
Cisco
CSCO
$438B
| $59.6M | 0.95% |
1,089,888
+703,240
| +182% | +$38.8M |
|
5
Home Depot
HD
$335B
| $58.3M | 0.93% |
280,108
+121,328
| +76% | +$24.2M |
|
6
Bristol-Myers Squibb
BMY
$137B
| $57.2M | 0.91% |
1,260,748
+340,589
| +37% | +$15.9M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $56.9M | 0.91% |
616,002
+45,679
| +8% | +$4.34M |
|
8
CVS Health
CVS
$119B
| $56.2M | 0.9% |
1,031,198
+347,789
| +51% | +$18.7M |
|
|
9
Eli Lilly
LLY
$1.12T
| $55.8M | 0.89% |
503,575
+257,782
| +105% | +$30.4M |
|
10
Accenture
ACN
$113B
| $55.7M | 0.89% |
301,334
+118,054
| +64% | +$21.2M |
|
|
11
Oracle
ORCL
$422B
| $52.5M | 0.84% |
921,379
+683,956
| +288% | +$37M |
|
12
Merck
MRK
$376B
| $50.5M | 0.81% |
630,734
+111,163
| +21% | +$8.51M |
|
13
Microsoft
MSFT
$3.59T
| $49.2M | 0.78% |
366,993
+36,829
| +11% | +$4.68M |
|
14
CSX Corp
CSX
$95.6B
| $48.8M | 0.78% |
1,893,111
+165,726
| +10% | +$4.27M |
|
15
Chevron
CVX
$403B
| $48.8M | 0.78% |
391,950
+92,010
| +31% | +$11.1M |
|
16
Verizon
VZ
$205B
| $47.7M | 0.76% |
834,864
-178,946
| -18% | -$10.3M |
|
17
Johnson & Johnson
JNJ
$651B
| $46.6M | 0.74% |
334,862
+113,272
| +51% | +$15.7M |
|
|
18
DuPont de Nemours
DD
$18.7B
| $46.4M | 0.74% |
492,771
+305,388
| +163% | +$36.5M |
|
|
19
Intuit
INTU
$100B
| $46.3M | 0.74% |
+177,339
| New | +$45.1M |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| $45.5M | 0.73% |
832,430
+184,739
| +29% | +$9.82M |
|
21
Walmart Inc
WMT
$825B
| $42.1M | 0.67% |
1,143,879
-211,989
| -16% | -$7.31M |
|
22
ConocoPhillips
COP
$162B
| $42M | 0.67% |
689,039
+307,439
| +81% | +$19.1M |
|
23
Johnson Controls International
JCI
$86.7B
| $40.2M | 0.64% |
973,349
+191,706
| +25% | +$7.37M |
|
24
VF Corp
VFC
$5.65B
| $39.8M | 0.64% |
455,911
+95,573
| +27% | +$8.23M |
|
25
Lockheed Martin
LMT
$130B
| $39.8M | 0.63% |
109,368
-16,424
| -13% | -$5.49M |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.